DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Reopro (Abciximab) - Adverse Event Reports - Hospitalization - Coronary Artery Disease

 



Index of reports > Cases resulting in hospitalization (14) > Cases with Coronary Artery Disease (2)

Below is the selection of adverse event reports related to Reopro (Abciximab) that includes cases resulting in hospitalization where reactions include coronary artery disease.

Adverse event in male receiving Reopro (Abciximab)

Reported by a physician from Italy on 2007-07-02

Patient: male, weighing 68.0 kg (149.6 pounds)

Adverse reactions / side effects: Gastrointestinal Haemorrhage, Gastritis Erosive, Coronary Artery Disease

Adverse event resulted in: hospitalization

Suspect drug(s):
Reopro
    Dosage: 4.0 ml in 50 ml of diluent at 3.4 ml/hr amount infused was unknown (total amount was not infused)

Reopro
    Indication: Acute Myocardial Infarction

Reteplase
    Indication: Acute Myocardial Infarction

Other drugs received by patient: Heparin; Heparin



Adverse event in 78 year old male receiving Reopro (Abciximab)

Reported by a physician from Poland on 2007-03-05

Patient: 78 year old male, weighing 70.0 kg (154.0 pounds)

Adverse reactions / side effects: Coronary Artery Dissection, Coronary Artery Disease, Coronary Artery Reocclusion, Cardiogenic Shock, Myocardial Infarction

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Reopro
    Dosage: an unspecified infusion

Reopro
    Indication: Percutaneous Coronary Intervention

Other drugs received by patient: Acetylsalicylic Acid SRT; Unfractionated Heparin; Clopidogrel

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009